Literature DB >> 21468941

Intact-protein analysis system for discovery of serum-based disease biomarkers.

Hong Wang1, Samir Hanash.   

Abstract

Profiling of serum and plasma proteins has substantial relevance to the discovery of circulating disease biomarkers. However, the extreme complexity and vast dynamic range of protein abundance in serum and plasma present a formidable challenge for protein analysis. Thus, integration of multiple technologies is required to achieve high-resolution and high-sensitivity proteomic analysis of serum or plasma. In this chapter, we describe an orthogonal multidimensional intact-protein analysis system (IPAS) (Wang et al., Mol Cell Proteomics 4:618-625, 2005) coupled with protein tagging (Faca et al., J Proteome Res 5:2009-2018, 2006) to profile the serum and plasma proteomes quantitatively, which we have applied in our biomarker discovery studies (Katayama et al., Genome Med 1:47, 2009; Faca et al., PLoS Med 5:e123, 2008; Zhang et al. Genome Biol 9:R93, 2008).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21468941      PMCID: PMC4677997          DOI: 10.1007/978-1-61779-068-3_4

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  21 in total

1.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.

Authors:  Andrew Keller; Alexey I Nesvizhskii; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2002-10-15       Impact factor: 6.986

Review 2.  Zooming in: fractionation strategies in proteomics.

Authors:  Taras Stasyk; Lukas A Huber
Journal:  Proteomics       Date:  2004-12       Impact factor: 3.984

3.  Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues. A novel approach to testing for induced point mutations in mammals.

Authors:  J Klose
Journal:  Humangenetik       Date:  1975

Review 4.  Biomedical applications of two-dimensional electrophoresis using immobilized pH gradients: current status.

Authors:  S M Hanash
Journal:  Electrophoresis       Date:  2000-04       Impact factor: 3.535

5.  Peroxiredoxin 6 is a potent cytoprotective enzyme in the epidermis.

Authors:  Angelika Kümin; Christine Huber; Thomas Rülicke; Eckhard Wolf; Sabine Werner
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

6.  Intact-protein-based high-resolution three-dimensional quantitative analysis system for proteome profiling of biological fluids.

Authors:  Hong Wang; Shawn G Clouthier; Vladimir Galchev; David E Misek; Ulrich Duffner; Chang-Ki Min; Rong Zhao; John Tra; Gilbert S Omenn; James L M Ferrara; Samir M Hanash
Journal:  Mol Cell Proteomics       Date:  2005-02-09       Impact factor: 5.911

7.  Plasma proteome profiling of a mouse model of breast cancer identifies a set of up-regulated proteins in common with human breast cancer cells.

Authors:  Sharon J Pitteri; Vitor M Faca; Karen S Kelly-Spratt; A Erik Kasarda; Hong Wang; Qing Zhang; Lisa Newcomb; Alexei Krasnoselsky; Sophie Paczesny; Gina Choi; Matthew Fitzgibbon; Martin W McIntosh; Christopher J Kemp; Samir M Hanash
Journal:  J Proteome Res       Date:  2008-02-27       Impact factor: 4.466

8.  Characterization of proteins in the human serum proteome.

Authors:  Edna Betgovargez; Vita Knudson; Michael H Simonian
Journal:  J Biomol Tech       Date:  2005-12

9.  Integrated proteomic analysis of human cancer cells and plasma from tumor bearing mice for ovarian cancer biomarker discovery.

Authors:  Sharon J Pitteri; Lellean JeBailey; Vitor M Faça; Jason D Thorpe; Melissa A Silva; Reneé C Ireton; Marc B Horton; Hong Wang; Liese C Pruitt; Qing Zhang; Kuang H Cheng; Nicole Urban; Samir M Hanash; Daniela M Dinulescu
Journal:  PLoS One       Date:  2009-11-19       Impact factor: 3.240

10.  Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.

Authors:  Xin-Zhong Chang; Da-Qiang Li; Yi-Feng Hou; Jiong Wu; Jin-Song Lu; Gen-Hong Di; Wei Jin; Zhou-Luo Ou; Zhen-Zhou Shen; Zhi-Ming Shao
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

View more
  5 in total

1.  Increased plasma levels of the APC-interacting protein MAPRE1, LRG1, and IGFBP2 preceding a diagnosis of colorectal cancer in women.

Authors:  Jon J Ladd; Tina Busald; Melissa M Johnson; Qing Zhang; Sharon J Pitteri; Hong Wang; Dean E Brenner; Paul D Lampe; Raju Kucherlapati; Ziding Feng; Ross L Prentice; Samir M Hanash
Journal:  Cancer Prev Res (Phila)       Date:  2012-01-25

Review 2.  Convergence of nanotechnology and cancer prevention: are we there yet?

Authors:  David G Menter; Sherri L Patterson; Craig D Logsdon; Scott Kopetz; Anil K Sood; Ernest T Hawk
Journal:  Cancer Prev Res (Phila)       Date:  2014-07-24

Review 3.  Analysis of protein isoforms: can we do it better?

Authors:  Miroslava Stastna; Jennifer E Van Eyk
Journal:  Proteomics       Date:  2012-09-19       Impact factor: 3.984

4.  A Comprehensive Search of Non-Canonical Proteins in Non-Small Cell Lung Cancer and Their Impact on the Immune Response.

Authors:  Ehsan Irajizad; Johannes F Fahrmann; James P Long; Jody Vykoukal; Makoto Kobayashi; Michela Capello; Chuan-Yih Yu; Yining Cai; Fu Chung Hsiao; Nikul Patel; Soyoung Park; Qian Peng; Jennifer B Dennison; Taketo Kato; Mei Chee Tai; Ayumu Taguchi; Humam Kadara; Ignacio I Wistuba; Hiroyuki Katayama; Kim-Anh Do; Samir M Hanash; Edwin J Ostrin
Journal:  Int J Mol Sci       Date:  2022-08-11       Impact factor: 6.208

5.  Plasma-Derived Extracellular Vesicles Convey Protein Signatures that Reflect Pathophysiology in Lung and Pancreatic Adenocarcinomas.

Authors:  Johannes F Fahrmann; Xiangying Mao; Ehsan Irajizad; Hiroyuki Katayama; Michela Capello; Ichidai Tanaka; Taketo Kato; Ignacio I Wistuba; Anirban Maitra; Edwin J Ostrin; Samir M Hanash; Jody Vykoukal
Journal:  Cancers (Basel)       Date:  2020-05-02       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.